Panadol Osteo referral: a first for the Minister

It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for the Minister told the AJP. The spokesperson says the Minister is also concerned about GSK’s market dominance and “misleading claims” and “justification” for the price